ArticleBMC plant biology2025
Effects of different shade treatments on Melaleuca seedling growth and physiological properties.
Article in BMC plant biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Effects of different light intensities on photosynthetic properties of endangered Primula filchnerae seedlings.Photosynthesis research · 2026Article
- Moderate Shading Improves Growth, Photosynthesis, and Physiological Traits inPlants (Basel, Switzerland) · 2025Article
- Physiological and transcriptomic analyses reveal the regulatory mechanisms for the adaptation of Quercus robur to shade conditions.BMC plant biology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
In light of the detrimental effects of global warming, exacerbated by the intense sunlight and high temperatures prevalent during summer in southern China, on the growth of Melaleuca alternifolia (M. alternifolia) seedlings, this study sets out to examine the impact of various shading treatments on the growth and physiological attributes of M. alternifolia seedlings, with the aim of determining the optimum shading level. The seedling phase is of paramount importance in the growth cycle and regeneration process of M. alternifolia, as both excessive and insufficient light exposure can negatively influence seedling development. Four shading regimes (CK: no shading; C1: 35-45% shading; C2: 45-50% shading; C3: 60-70% shading) were imposed on M. alternifolia seedlings, following which observations were conducted after a 35-day period. The results reveal that the different shading treatments had a significant effect on the growth and physiological indicators of the seedlings, with the moderate shading treatment (C2) proving to be the most advantageous for seedling growth. Under the C2 treatment, an increase in chlorophyll content was observed in the leaves of the seedlings, accompanied by a decrease in malondialdehyde (MDA) content. Concurrently, there was a reduction in the activities of antioxidant enzymes, namely superoxide dismutase (SOD), peroxidase (POD), and catalase (CAT). Furthermore, the levels of abscisic acid (ABA) and gibberellic acid (GA3) declined, while the concentrations of auxin (IAA), salicylic acid (SA), and cytokinin (CTK) ascended. Leaf anatomical analysis disclosed that, in comparison to the control group, the thickness of the lower epidermis and palisade tissue in the leaves of the seedlings subjected to the C2 treatment exhibited a significant reduction. Additionally, an increase in the number of spongy tissue cells was noted, along with a marked increase in total leaf thickness. Consequently, cultivating M. alternifolia seedlings under shading conditions ranging from 45 to 50% is deemed more favorable. The findings of this study offer novel insights into the adaptive responses of M. alternifolia seedlings to varying light intensities and provide theoretical guidance for the cultivation and management of M. alternifolia seedlings in the southern regions of China.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.